MOVE GROSSE POINT BLANK: CHARACTER MARTIN BLANK FAMILY HX: MOTHER WITH SEVERE SCHIZOPHRENIA MARTIN BLANK DIAGNOSIS ANTISOCIAL PERSONALITY DISORDER WITH CO-OCCURING , PRODROMAL STAGE SCHIZOPHRENIA WITH INITIAL SYMPTOM ANHEDONIA. PROM NIGHT FIRST URGE TO KILL SOMEONE, GOT SCARED OF THE FEELING AND JOINED THE ARMY, BECAME A HIT MAN FOR THE GOVERNMENT AND ULIMATELY A HIT MAN IN BUSINESS FOR HIMSELF.
NO REMORSE WITH KILLING, NO BELIEF IN MORALITY MARTIN BEGAN HAVINGT SYMPTOMS OF DEPRESSION, WONDERING ABOUT THE MEANING OF LIFE SOUGHT COUNSELING. 10 YEAR HIGH SCHOOL REUNION CAME UP, MARTIN SAW HIS PAST HIGH SCHOOL LOVE, KILLED AT HIS HIGH SCHOOL REUNION THEN
KILLED MULTIPLE MORE PEOPLE SAVING HER FATHER. IMPORTANCE OF MANAGING SYMPTOMS AND POSSIBLE PREVENTION OF RELAPSE. CONSISTENT COUNSELING, WARNING SIGNS the prevalence of antisocial personality disorder is higher in patients with schizophrenia than in normal population.
In their study on 232 male schizophrenic patients, 75% who had committed a crime at least once showed antisocial personality traits 1. Introduction Paragraph Discussing: (a) your primary differential diagnosis, (b) current state of the science in treating this diagnosis, (c) the epidemiologic incidence and prevalence of the diagnosis in the United States, (d) a statement or two about limitations or challenges known to treating this diagnosis.
2. Describe your patient taken from the movie clip (be sure to cite the character and the movie name) with as much information as you have available.
Describe the patient’s appearance and mental status exam and their symptoms as presented in the movie clip.
3. Describe the Assessment as DSM 5 Differential Diagnoses you have developed for the patient. Discuss alternative possible hypotheses for their symptoms, including psychiatric, mental health, and medical comorbid possibilities.
4. Describe your proposed treatment plan, including prescribed, alternative, and over the counter medications. Include what precise neurotransmitters you will be targeting based on the patient’s symptoms.
Discuss if its FDA approved and if not, discuss your rationale for deviation. Discuss the risks and benefits of the proposed regimen and answer the following questions:
a) How and when would you need to collaborate with a physician for this patient? b) How will you obtain informed consent?
c) How will you educate the patient on risks vs benefits?
d) Describe the risks?
e) What is your alternative plan if the patient does not tolerate the regimen?
f) What anticipatory guidance will you provide?
g) How will you instruct the patient on managing side effects?
h) What will be your medication reconciliation plan? Include interactions, duplicate therapy risks.
I) How will you consider the risks of nonadherence for this particular patient?
J) What are the foreseeable risks of involving family members or caregivers in the plan?
k) What diagnostic or lab testing is needed to confirm the diagnosis and what will be needed to provide ongoing monitoring for the medications you have selected. When you consider the risks vs benefits, please use a theoretical framework that considers the social determinants of health.
5. Rationale for selecting this plan vs alternative options. This section should include a brief literature review to support your rationales.
6. Disposition This section discusses your summary of your diagnosis and plan and primary reason for selecting this plan. The primary reasons should focus heavily on specific quality-of-life improvement (using available evidence-based literature) also discuss the costs, access issues (Ie. insurance coverage, etc. ).
Discuss how frequently the patient should be monitored. Is this a high-risk plan or not and the rationale for this assumption?
Restate any adherence issues you anticipate and how you are off setting this and any risks to the patient.
